Surgical Innovations Group Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Surgical Innovations Group te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei	23.1%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	18 Apr 2024

Recente toekomstige groei-updates

Recent updates

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Jul 11

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Surgical Innovations Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

AIM:SUN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (GBP Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2024	12	N/A	1	N/A	1
6/30/2024	13	-1	-1	0	N/A
3/31/2024	12	-1	0	0	N/A
12/31/2023	12	-1	0	0	N/A
9/30/2023	12	0	-1	0	N/A
6/30/2023	12	0	-1	0	N/A
3/31/2023	11	0	-1	0	N/A
12/31/2022	11	0	-1	0	N/A
9/30/2022	11	0	-1	0	N/A
6/30/2022	10	0	-1	0	N/A
3/31/2022	10	0	-1	0	N/A
12/31/2021	9	0	-1	0	N/A
9/30/2021	9	-1	0	0	N/A
6/30/2021	8	-1	0	0	N/A
3/31/2021	7	-2	1	1	N/A
12/31/2020	6	-3	1	1	N/A
9/30/2020	7	-4	1	1	N/A
6/30/2020	8	-5	1	1	N/A
3/31/2020	9	-4	0	1	N/A
12/31/2019	11	-3	0	1	N/A
9/30/2019	11	-1	0	1	N/A
6/30/2019	11	0	0	1	N/A
3/31/2019	11	1	1	1	N/A
12/31/2018	11	1	1	2	N/A
9/30/2018	11	1	1	2	N/A
6/30/2018	11	0	1	2	N/A
3/31/2018	10	0	N/A	2	N/A
12/31/2017	9	0	N/A	2	N/A
9/30/2017	8	1	N/A	2	N/A
6/30/2017	7	1	N/A	2	N/A
3/31/2017	6	1	N/A	2	N/A
12/31/2016	6	1	N/A	3	N/A
9/30/2016	6	0	N/A	3	N/A
6/30/2016	6	0	N/A	3	N/A
3/31/2016	6	-1	N/A	2	N/A
12/31/2015	5	-2	N/A	2	N/A
9/30/2015	5	-5	N/A	1	N/A
6/30/2015	5	-9	N/A	0	N/A
3/31/2015	4	-9	N/A	0	N/A
12/31/2014	4	-9	N/A	0	N/A
9/30/2014	5	-6	N/A	0	N/A
6/30/2014	5	-3	N/A	1	N/A
3/31/2014	6	-1	N/A	1	N/A
12/31/2013	7	0	N/A	1	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van SUN boven de spaarquote ( 1.9% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van SUN naar verwachting sneller zal groeien dan de markt UK

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van SUN naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van SUN naar verwachting sneller zal groeien dan de markt UK.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van SUN naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van SUN naar verwachting over 3 jaar hoog zal zijn

Surgical Innovations Group Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Price target decreased to UK£0.033

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Recent updates

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0 in 1H 2023)

New major risk - Financial position

Surgical Innovations Group plc to Report First Half, 2024 Results on Sep 30, 2024

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Surgical Innovations Group plc, Annual General Meeting, Jun 17, 2024

New major risk - Share price stability

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Full year 2023 earnings released

Surgical Innovations Group plc to Report Fiscal Year 2023 Results on Apr 18, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Surgical Innovations Group plc Announces Intention of Paul Hardy to Step Down from Position of Independent Non-Executive Director

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Charmaine Day Notifies the Board of Her Intention to Step Down from Her Role as Chief Financial Officer of Surgical Innovations Group plc

Surgical Innovations Group plc Announces Board Change

First half 2023 earnings released: EPS: UK£0 (vs UK£0 in 1H 2022)

Surgical Innovations Group plc to Report First Half, 2023 Results on Sep 19, 2023

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2023

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Surgical Innovations Group plc Appoints Jonathan Glenn as Senior Independent Non-Executive Director and Chairman-Designate

Full year 2022 earnings released: EPS: UK£0 (vs UK£0 in FY 2021)

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021)

Surgical Innovations Group plc to Report First Half, 2022 Results on Sep 21, 2022

Surgical Innovations Group plc Ordinary Shares to Be Deleted from OTC Equity

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2022

Price target decreased to UK£0.033

Less than half of directors are independent

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Surgical Innovations Group plc to Report Fiscal Year 2020 Results on Mar 25, 2021

Surgical Innovations Group plc Announces New USA Distribution Agreement with Microline Surgical Inc

Surgical Innovations Group plc Announces Adam Power Will Retire as Group Development Director, with Effect from 31 December 2021

Surgical Innovations Group plc Announces Distribution Agreement with Adler Instrument Company Inc

Surgical Innovations Group plc Announces its Collaboration with the Centre for Sustainable Healthcare

First half earnings released

Surgical Innovations Group plc to Report First Half, 2020 Results on Sep 08, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven